Glycan masking in immunogen design: computational and experimental methods
Epitope-focused vaccine design aims to improve upon existing immunization strategies by eliciting immune responses against specific epitopes targeted by known therapeutic antibodies. One of the techniques in epitope-focused immunogen design is glycan masking, in which sugars are used to hide epitopes on the protein of interest that are associated with low therapeutic potency. Here, we provide a detailed overview of the computational and experimental techniques associated with glycan masking for immunogen design at a biochemical and biophysical level. We will cover well-established and emerging <i>in silico</i> methods for predicting and engineering glycosylation sites. Additionally, we will discuss expression and validation of glycosylated immunogens <i>in vitro</i>. We hope this review will be a useful overview for scientists interested in performing glycan masking in their field of research.
Authors
- Kyle L. Brown (ORCID: https://orcid.org/0000-0002-7671-1912)
- Cristina E. Martina (ORCID: https://orcid.org/0000-0001-6526-9180)
- Minh H. Tran (ORCID: https://orcid.org/0000-0002-3093-3659)
- Hannah Vogts
- Josuel Morel
- Shan Jiang (ORCID: https://orcid.org/0000-0003-4736-4680)
- Sean Murray
- Jens Meiler
- Emika Miyamoto
- Gustavo Araiza
Institutions
- University of Iowa (US)
- Vanderbilt University (US)
- Artificial Intelligence in Medicine (Canada) (CA)
- Belmont University (US)
- Vanderbilt University Medical Center (US)
- Leipzig University (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3389/fimmu.2025.1726810
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- Advanced Research Projects Agency